Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.43 USD | +6.24% | -58.64% | -65.25% |
08/05 | Top Midday Decliners | MT |
08/05 | UBS Adjusts Price Target on Treace Medical Concepts to $16 From $17, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.25% | 275M | |
+73.46% | 12.41B | |
-16.75% | 8.12B | |
+5.93% | 6.59B | |
-6.11% | 5.83B | |
+13.79% | 5.46B | |
+40.99% | 5.05B | |
-19.05% | 4.02B | |
-34.55% | 2.47B | |
-0.99% | 2.02B |
- Stock Market
- Equities
- TMCI Stock
- News Treace Medical Concepts, Inc.
- Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024